Nissan Medical Industries Ltd Nissan Medical Industries Ltd (NISA.TA) is an Israel-based company that engages in the production of surgical dressing products and the manufacturing and marketing of gauze and non-woven fabrics, primarily using spunlace water entanglement technology. The company offers a comprehensive range of core products including gauze and non-woven swabs, absorbent pads, absorbent balls, laparotomy sponges, bandages, kits, double peel-packs, and orthopedic padding; these are supplied to medical centers, pharmacies, defense forces, and private hospitals in Israel and abroad, with operations extending to the United States and Canada through subsidiaries. Founded in January 1984 by Yeheskel Nissan and headquartered at 11 Harugei Malkhut Street in Tel Aviv, Israel, the company operates in the medical equipment, supplies, and distribution sector, serving healthcare and hygienic applications.
In recent developments, Nissan Medical Industries Ltd reported a net loss of ₪0.22 per share for the first quarter of 2025, reflecting an 18% revenue decline to ₪157.9 million amid operational challenges. The company maintains a workforce of approximately 406 employees and continues to focus on its core non-woven fabric production without notable acquisitions, partnerships, funding rounds, or major strategic shifts announced in the last 1-2 years. Its shares trade on the Tel Aviv Stock Exchange with a recent market capitalization of around 93.47 million ILS and a high dividend yield exceeding 19%.